A Phase 2 Double Blinded, Randomized Controlled Trial of Saroglitazar in Patients with Nonalcoholic Steatohepatitis.

Siddiqui MS, Idowu MO, Parmar D, Borg BB, Denham D, Loo NM, Lazas D, Younes Z, Sanyal AJ. Clin Gastroenterol Hepatol. 2020 Nov 2:S1542-3565(20)31509-3. doi: 10.1016/j.cgh.2020.10.051.

in cat NOT

Stay Connected

Would you like to receive updates from ProSciento?